(Q46201689)

20 December 2017

title

10th annual meeting of the Safety Pharmacology Society: an overview (English)

1 reference

20 December 2017

1 reference

Icilio Cavero

1

1 reference

20 December 2017

language of work or name

English

0 references

publication date

14 February 2011

1 reference

20 December 2017

Expert Opinion on Drug Safety

published in

1 reference

20 December 2017

volume

10

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

319-333

1 reference

20 December 2017

Safety Pharmacology Society: 5th annual meeting

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

Safety Pharmacology Society: 9th Annual Meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

A conversation with Robert Langer: pioneering biomedical scientist and engineer. Interview by Paul S. Weiss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

21 January 2018

Drug-induced arrhythmia

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

Deconstructing the drug development process: the new face of innovation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

Prediction of drug-related cardiac adverse effects in humans--A: creation of a database of effects and identification of factors affecting their occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

Novel method to assess cardiac electrophysiology in the rat: characterization of standard ion channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

The prototype serotonin 5-HT 1B/1D agonist sumatriptan increases the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

Approaches to seizure risk assessment in preclinical drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

Productivity Shortfalls in Drug Discovery: Contributions from the Preclinical Sciences?: TABLE 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.555980

10.1517/14740338.2011.555980

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017